Motif ID: Zfx_Zfp711
Z-value: 2.419


Transcription factors associated with Zfx_Zfp711:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Zfp711 | ENSMUSG00000025529.8 | Zfp711 |
Zfx | ENSMUSG00000079509.4 | Zfx |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Zfp711 | mm10_v2_chrX_+_112604274_112604274 | -0.27 | 8.6e-02 | Click! |
Zfx | mm10_v2_chrX_-_94123087_94123159 | 0.15 | 3.3e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0021998 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) positive regulation of cardiac ventricle development(GO:1904414) |
1.5 | 6.2 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
1.4 | 8.2 | GO:0003383 | apical constriction(GO:0003383) |
1.2 | 3.7 | GO:0060853 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel endothelial cell fate specification(GO:0097101) |
1.2 | 3.6 | GO:1900275 | negative regulation of phospholipase C activity(GO:1900275) |
1.2 | 4.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
1.2 | 1.2 | GO:1904412 | regulation of cardiac ventricle development(GO:1904412) |
1.2 | 4.7 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
1.1 | 1.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
1.1 | 4.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
1.1 | 3.2 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
1.0 | 3.1 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
1.0 | 5.0 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
1.0 | 3.0 | GO:0021972 | corticospinal neuron axon guidance through spinal cord(GO:0021972) positive regulation of negative chemotaxis(GO:0050924) induction of negative chemotaxis(GO:0050929) negative regulation of mononuclear cell migration(GO:0071676) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
1.0 | 2.9 | GO:0060364 | frontal suture morphogenesis(GO:0060364) |
0.9 | 0.9 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.9 | 2.8 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.9 | 2.8 | GO:0030421 | defecation(GO:0030421) |
0.9 | 2.8 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.9 | 2.8 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.9 | 2.7 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.9 | 1.8 | GO:0001743 | optic placode formation(GO:0001743) |
0.9 | 8.0 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.9 | 2.6 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.9 | 5.2 | GO:0048105 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
0.9 | 2.6 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.8 | 3.4 | GO:0090472 | dibasic protein processing(GO:0090472) |
0.8 | 4.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.8 | 1.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.8 | 2.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.8 | 3.2 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
0.8 | 1.6 | GO:0035065 | regulation of histone acetylation(GO:0035065) |
0.8 | 3.9 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
0.8 | 3.9 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
0.8 | 3.9 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.8 | 2.3 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
0.8 | 0.8 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.8 | 6.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.8 | 2.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.7 | 2.2 | GO:0035878 | nail development(GO:0035878) |
0.7 | 2.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 2.9 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.7 | 2.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.7 | 4.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.7 | 3.6 | GO:0021905 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
0.7 | 2.8 | GO:1904393 | regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) |
0.7 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.7 | 2.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.7 | 2.8 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.7 | 2.1 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.7 | 0.7 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.7 | 2.0 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.7 | 2.0 | GO:0003349 | epicardium-derived cardiac endothelial cell differentiation(GO:0003349) |
0.7 | 1.3 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.7 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.7 | 2.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.7 | 2.6 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.6 | 0.6 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.6 | 1.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.6 | 1.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.6 | 4.2 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.6 | 2.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.6 | 1.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.6 | 3.0 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.6 | 2.9 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.6 | 1.8 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.6 | 0.6 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.6 | 1.7 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.6 | 1.7 | GO:0014028 | notochord formation(GO:0014028) |
0.6 | 1.7 | GO:0060982 | coronary artery morphogenesis(GO:0060982) |
0.6 | 1.7 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
0.6 | 0.6 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
0.6 | 1.7 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.6 | 1.1 | GO:0072236 | metanephric loop of Henle development(GO:0072236) |
0.6 | 3.9 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.6 | 2.2 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.5 | 2.7 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.5 | 2.2 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.5 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.5 | 2.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) positive regulation of mesoderm development(GO:2000382) |
0.5 | 1.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 0.5 | GO:0051155 | positive regulation of striated muscle cell differentiation(GO:0051155) |
0.5 | 0.5 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.5 | 2.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.5 | 2.1 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.5 | 0.5 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.5 | 2.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.5 | 1.6 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.5 | 2.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.5 | 2.0 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.5 | 1.5 | GO:0090004 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.5 | 1.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.5 | 2.0 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.5 | 1.0 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.5 | 5.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.5 | 1.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 3.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 0.5 | GO:0039519 | modulation by virus of host autophagy(GO:0039519) |
0.5 | 0.5 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
0.5 | 1.5 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.5 | 2.0 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.5 | 1.5 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.5 | 2.0 | GO:0097298 | regulation of nucleus size(GO:0097298) |
0.5 | 2.9 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
0.5 | 1.5 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.5 | 0.5 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.5 | 4.3 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.5 | 1.0 | GO:0048840 | otolith development(GO:0048840) |
0.5 | 1.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.5 | 2.4 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.5 | 1.4 | GO:0072180 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
0.5 | 1.4 | GO:0014877 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.5 | 1.9 | GO:0072362 | regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072362) regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
0.5 | 1.4 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.5 | 1.9 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.5 | 5.0 | GO:0007440 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.5 | 1.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
0.5 | 1.8 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
0.4 | 1.8 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.4 | 2.2 | GO:0015871 | choline transport(GO:0015871) |
0.4 | 0.4 | GO:1904173 | regulation of histone demethylase activity (H3-K4 specific)(GO:1904173) |
0.4 | 0.4 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.4 | 1.3 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.4 | 4.4 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 5.3 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.4 | 1.8 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.4 | 0.4 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
0.4 | 0.4 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
0.4 | 1.3 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 | 1.3 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.4 | 0.4 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.4 | 1.3 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 1.3 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.4 | 1.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.4 | 2.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.4 | 1.3 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.4 | 1.3 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.4 | 2.1 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) |
0.4 | 7.5 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.4 | 3.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 1.2 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.4 | 0.4 | GO:0031016 | pancreas development(GO:0031016) |
0.4 | 3.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 0.8 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
0.4 | 1.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.4 | 0.4 | GO:2000054 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
0.4 | 1.6 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.4 | 2.4 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.4 | 1.2 | GO:0060558 | regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.4 | 2.0 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.4 | 4.0 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.4 | 2.0 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.4 | 0.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
0.4 | 1.2 | GO:0060003 | copper ion export(GO:0060003) |
0.4 | 2.0 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
0.4 | 2.3 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
0.4 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.2 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.4 | 7.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.4 | 1.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 3.9 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 1.2 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.4 | 2.3 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.4 | 1.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
0.4 | 0.8 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.4 | 3.4 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.4 | 1.1 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.4 | 1.1 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 0.4 | GO:0080144 | amino acid homeostasis(GO:0080144) |
0.4 | 1.5 | GO:0044805 | late nucleophagy(GO:0044805) |
0.4 | 1.1 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) |
0.4 | 1.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.4 | 1.8 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.4 | 2.2 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.4 | 1.4 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.4 | 1.8 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 2.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.4 | 1.4 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.4 | 1.1 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.4 | 0.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.4 | 2.1 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.4 | 0.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.4 | 1.4 | GO:0070829 | heterochromatin maintenance(GO:0070829) |
0.4 | 1.8 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.3 | 0.3 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.3 | 11.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.3 | 0.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.3 | 1.0 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.3 | 3.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.3 | 0.7 | GO:0048793 | pronephros development(GO:0048793) |
0.3 | 1.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.3 | 0.3 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.3 | 1.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.3 | 1.0 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.3 | 1.0 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.3 | 0.3 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.3 | 0.3 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 0.7 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.3 | 1.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.3 | 2.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 0.6 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) sclerotome development(GO:0061056) |
0.3 | 1.0 | GO:0003357 | noradrenergic neuron differentiation(GO:0003357) |
0.3 | 2.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 0.3 | GO:0090024 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
0.3 | 0.3 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.3 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
0.3 | 0.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.3 | 1.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.3 | 0.9 | GO:1904504 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
0.3 | 0.3 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.3 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 1.3 | GO:1900086 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.3 | 0.9 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.3 | 1.6 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 0.6 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.3 | 0.3 | GO:0000578 | embryonic axis specification(GO:0000578) |
0.3 | 3.7 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.3 | 2.7 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.3 | 0.9 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
0.3 | 1.2 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.2 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.3 | 0.9 | GO:0048698 | regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 0.3 | GO:0016078 | tRNA catabolic process(GO:0016078) |
0.3 | 0.6 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.3 | 0.9 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.3 | 0.3 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.3 | 0.3 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.3 | 0.6 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 1.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 0.9 | GO:1904192 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
0.3 | 0.9 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.3 | 0.3 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.3 | 1.5 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.3 | 0.3 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 1.8 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.3 | 1.8 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.3 | 1.2 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.3 | 0.3 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.3 | 1.8 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.3 | 1.8 | GO:0051096 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.3 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 1.2 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.3 | 0.9 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.3 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 2.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.3 | 0.6 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.3 | 1.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.3 | 1.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.3 | 0.3 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 2.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.3 | 1.1 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.3 | 0.3 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.3 | 1.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.3 | 0.8 | GO:0060821 | inactivation of X chromosome by DNA methylation(GO:0060821) |
0.3 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.3 | 0.5 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
0.3 | 4.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.3 | 9.8 | GO:0007520 | myoblast fusion(GO:0007520) |
0.3 | 0.5 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.3 | 3.0 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.3 | 1.1 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.3 | 0.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.3 | 0.5 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 0.8 | GO:0016598 | protein arginylation(GO:0016598) |
0.3 | 2.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.3 | 1.9 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.3 | 0.8 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
0.3 | 2.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.3 | 1.6 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.3 | 3.4 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 1.6 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
0.3 | 0.5 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.3 | 0.8 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
0.3 | 0.3 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.3 | 0.3 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.3 | 0.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.3 | 1.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.3 | 1.6 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.3 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.3 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.3 | 1.5 | GO:0072718 | response to cisplatin(GO:0072718) |
0.3 | 1.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.0 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.3 | 0.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.3 | 0.8 | GO:0015677 | copper ion import(GO:0015677) |
0.3 | 0.5 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.3 | 0.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.3 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 1.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.5 | GO:0034287 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.7 | GO:1905034 | regulation of antifungal innate immune response(GO:1905034) negative regulation of antifungal innate immune response(GO:1905035) |
0.2 | 2.5 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 2.0 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.2 | 0.5 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
0.2 | 1.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 1.2 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.2 | 2.4 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 0.2 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.2 | 1.0 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.2 | 1.2 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.2 | 1.9 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.2 | 1.7 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.2 | 0.2 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.2 | 0.2 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.2 | 1.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.2 | 3.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.2 | GO:1900145 | regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) |
0.2 | 3.8 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.2 | 0.9 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.2 | GO:1902915 | regulation of protein K63-linked ubiquitination(GO:1900044) negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 1.4 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.2 | 1.2 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.2 | 0.9 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.2 | 0.7 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.2 | 1.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.5 | GO:0050904 | diapedesis(GO:0050904) |
0.2 | 2.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.2 | 0.7 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
0.2 | 0.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.2 | 0.2 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.2 | 0.7 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.2 | 1.8 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
0.2 | 3.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.7 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.2 | 0.2 | GO:1904938 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.2 | 0.9 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.2 | 0.9 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 1.8 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.2 | 0.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.5 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.2 | 0.2 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
0.2 | 2.2 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.2 | 1.6 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.2 | 1.1 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.2 | 0.4 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
0.2 | 0.2 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.2 | 0.2 | GO:1990776 | cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.2 | 0.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.2 | 2.6 | GO:0001675 | acrosome assembly(GO:0001675) |
0.2 | 1.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 0.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.2 | 0.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 1.3 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.2 | 0.4 | GO:0045343 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.2 | 0.6 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.2 | 0.4 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.2 | 0.4 | GO:0031554 | regulation of DNA-templated transcription, termination(GO:0031554) |
0.2 | 0.2 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.2 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.2 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 0.6 | GO:0097502 | mannosylation(GO:0097502) |
0.2 | 1.5 | GO:0072615 | interleukin-17 secretion(GO:0072615) |
0.2 | 0.6 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
0.2 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.2 | 1.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.2 | 0.8 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.2 | 1.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.2 | 0.4 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.2 | 1.0 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 0.8 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 0.4 | GO:0071211 | protein targeting to vacuole involved in autophagy(GO:0071211) |
0.2 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.2 | 0.8 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.2 | 0.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.6 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.2 | 0.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.4 | GO:0060872 | semicircular canal development(GO:0060872) |
0.2 | 1.2 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.4 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.2 | 1.2 | GO:0030913 | paranodal junction assembly(GO:0030913) |
0.2 | 0.8 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.2 | 0.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 1.6 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.2 | 5.9 | GO:0035411 | catenin import into nucleus(GO:0035411) |
0.2 | 1.8 | GO:1904152 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) regulation of retrograde protein transport, ER to cytosol(GO:1904152) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.6 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.2 | 1.8 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.2 | 0.6 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.4 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.2 | 0.8 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.2 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.2 | 1.3 | GO:0015675 | nickel cation transport(GO:0015675) |
0.2 | 0.8 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.2 | 2.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.6 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.2 | 1.0 | GO:0031652 | positive regulation of heat generation(GO:0031652) |
0.2 | 0.8 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.2 | 1.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.2 | 1.9 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.2 | 1.9 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 1.1 | GO:0032196 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) transposition(GO:0032196) |
0.2 | 1.7 | GO:0009644 | response to high light intensity(GO:0009644) |
0.2 | 1.1 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.2 | 0.2 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
0.2 | 0.7 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
0.2 | 0.9 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.4 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.6 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.2 | 1.1 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.2 | 1.3 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.2 | 0.4 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.2 | 0.2 | GO:1990009 | retinal cell apoptotic process(GO:1990009) |
0.2 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 1.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 0.5 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.2 | 1.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.2 | 1.3 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.2 | 0.5 | GO:0060372 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) |
0.2 | 1.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.2 | 0.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) positive regulation of eosinophil migration(GO:2000418) |
0.2 | 0.4 | GO:0090274 | positive regulation of somatostatin secretion(GO:0090274) |
0.2 | 1.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.2 | 0.9 | GO:1901525 | negative regulation of macromitophagy(GO:1901525) |
0.2 | 3.2 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
0.2 | 5.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.2 | 0.2 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.2 | 0.4 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.2 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
0.2 | 2.8 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.2 | 0.2 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.2 | 0.9 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.2 | 0.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 0.2 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.2 | 0.3 | GO:0046671 | negative regulation of retinal cell programmed cell death(GO:0046671) |
0.2 | 0.7 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.2 | 0.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.2 | 1.5 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.2 | 1.7 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 0.2 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.2 | 1.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.5 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 0.7 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 1.0 | GO:0015074 | DNA integration(GO:0015074) |
0.2 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
0.2 | 1.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.8 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.2 | 1.0 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 0.8 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 0.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.2 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 0.5 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.2 | 0.8 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
0.2 | 0.7 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.2 | 0.3 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.2 | 4.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 1.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.2 | 0.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.2 | 1.3 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.2 | 0.8 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.2 | 0.6 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.2 | 2.4 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.2 | 0.6 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.2 | 0.3 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.2 | 5.6 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.2 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.2 | 0.5 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.2 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.2 | 2.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.2 | 1.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 0.6 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.2 | 1.7 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.2 | 0.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 3.2 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.2 | 0.8 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.2 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 1.4 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.2 | 1.1 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.2 | 4.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.2 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.2 | 0.5 | GO:0090166 | Golgi disassembly(GO:0090166) |
0.2 | 0.9 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.5 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) |
0.2 | 0.2 | GO:0034968 | histone lysine methylation(GO:0034968) |
0.2 | 1.1 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.2 | 0.2 | GO:0060443 | mammary gland morphogenesis(GO:0060443) |
0.2 | 0.5 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.5 | GO:2000678 | negative regulation of transcription regulatory region DNA binding(GO:2000678) |
0.2 | 0.2 | GO:1905165 | regulation of lysosomal protein catabolic process(GO:1905165) |
0.2 | 0.5 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.2 | 0.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.2 | 1.4 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.2 | 2.3 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.2 | 2.7 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 0.9 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.1 | 0.3 | GO:1902022 | L-lysine transport(GO:1902022) |
0.1 | 0.1 | GO:0046668 | retinal cell programmed cell death(GO:0046666) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 1.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.1 | 0.3 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.3 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.1 | 0.3 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.1 | 0.9 | GO:0048675 | axon extension(GO:0048675) |
0.1 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
0.1 | 0.1 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 0.3 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) |
0.1 | 0.4 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.3 | GO:0001840 | neural plate development(GO:0001840) |
0.1 | 0.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
0.1 | 0.9 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0035089 | establishment of apical/basal cell polarity(GO:0035089) |
0.1 | 0.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.1 | 0.3 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 0.6 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.1 | GO:0015747 | urate transport(GO:0015747) |
0.1 | 0.6 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.1 | GO:0042264 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.4 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.3 | GO:0071772 | response to BMP(GO:0071772) cellular response to BMP stimulus(GO:0071773) |
0.1 | 0.4 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 1.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 1.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.4 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.1 | 0.6 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.1 | 1.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.3 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.1 | 0.8 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.1 | 0.3 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 1.3 | GO:0002467 | germinal center formation(GO:0002467) |
0.1 | 1.0 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 1.7 | GO:0030220 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 0.4 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 0.3 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
0.1 | 1.2 | GO:0098868 | endochondral bone growth(GO:0003416) bone growth(GO:0098868) |
0.1 | 1.4 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
0.1 | 0.3 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.1 | 1.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.7 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.5 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.1 | 1.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 0.3 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.7 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.1 | 0.8 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 1.3 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
0.1 | 0.8 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
0.1 | 0.8 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.8 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.1 | 0.5 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.3 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.1 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.1 | 1.6 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.4 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 0.8 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 1.3 | GO:0060736 | prostate gland growth(GO:0060736) |
0.1 | 0.4 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.1 | 0.8 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.1 | 0.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.1 | GO:0043586 | tongue development(GO:0043586) |
0.1 | 2.2 | GO:0001707 | mesoderm formation(GO:0001707) |
0.1 | 1.0 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.1 | 0.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 2.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.1 | 0.9 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.1 | 0.5 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.5 | GO:0035547 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.1 | 0.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.1 | 0.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 1.7 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.1 | 0.5 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.5 | GO:0021764 | amygdala development(GO:0021764) |
0.1 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.9 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 1.1 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.1 | 1.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.1 | 1.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.4 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.1 | 2.3 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.9 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.1 | 0.9 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.1 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.1 | 1.2 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.1 | 3.3 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.1 | 0.8 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.1 | 2.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.6 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.2 | GO:0060525 | prostate glandular acinus development(GO:0060525) |
0.1 | 0.1 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.1 | 0.4 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.1 | 0.5 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.1 | 1.2 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.6 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.6 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.1 | 1.5 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.7 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 1.2 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.6 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.7 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.1 | 0.6 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.1 | 0.6 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.8 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.9 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.3 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
0.1 | 0.3 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.1 | 0.3 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) |
0.1 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.1 | 0.3 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.1 | 0.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.1 | 0.1 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
0.1 | 0.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.4 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.3 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.1 | 0.5 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
0.1 | 0.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.1 | 0.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 0.4 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.1 | 0.2 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.1 | 0.4 | GO:0032328 | alanine transport(GO:0032328) |
0.1 | 0.3 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 2.1 | GO:0003382 | epithelial cell morphogenesis(GO:0003382) |
0.1 | 0.3 | GO:0045004 | DNA replication proofreading(GO:0045004) |
0.1 | 0.1 | GO:2000121 | regulation of superoxide dismutase activity(GO:1901668) regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.2 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 0.4 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
0.1 | 2.0 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.1 | 0.4 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.1 | 0.4 | GO:0055118 | negative regulation of cardiac muscle contraction(GO:0055118) |
0.1 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.1 | 1.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 1.6 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.1 | 0.2 | GO:1905154 | negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
0.1 | 0.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 1.1 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.1 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.3 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.7 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.4 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.3 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.1 | 0.2 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 1.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 0.4 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.1 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
0.1 | 0.8 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.1 | 0.4 | GO:0070162 | adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 0.3 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.1 | 0.2 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 0.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.6 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.2 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
0.1 | 0.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.1 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.1 | 0.8 | GO:2000169 | regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.1 | 0.3 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.1 | 0.3 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.5 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.1 | 0.1 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
0.1 | 0.6 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.3 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.1 | 0.5 | GO:1904738 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.1 | 1.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 1.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.6 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.7 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
0.1 | 0.2 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.9 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.6 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 1.0 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glucose 6-phosphate metabolic process(GO:0051156) |
0.1 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.5 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.1 | 1.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.1 | 0.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.3 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 1.0 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 1.5 | GO:0044804 | nucleophagy(GO:0044804) |
0.1 | 0.4 | GO:0032898 | neurotrophin production(GO:0032898) |
0.1 | 0.1 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.2 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.3 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) |
0.1 | 1.2 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
0.1 | 0.7 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.9 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 0.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
0.1 | 0.8 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.1 | 1.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.1 | 0.4 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 1.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.1 | 1.0 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.1 | 0.5 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.1 | 0.1 | GO:0043628 | rRNA 3'-end processing(GO:0031125) ncRNA 3'-end processing(GO:0043628) |
0.1 | 0.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.1 | 0.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.1 | 0.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.1 | 0.2 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 0.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 0.6 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 3.3 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.1 | 0.1 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.1 | 0.2 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
0.1 | 0.2 | GO:0051031 | tRNA transport(GO:0051031) |
0.1 | 0.6 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.1 | 1.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.4 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 4.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.1 | 0.2 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
0.1 | 0.5 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.1 | 0.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.2 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 1.0 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
0.1 | 0.2 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.7 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.9 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.1 | 0.1 | GO:1901796 | regulation of signal transduction by p53 class mediator(GO:1901796) |
0.1 | 0.5 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.2 | GO:0033687 | osteoblast proliferation(GO:0033687) |
0.1 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
0.1 | 0.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:0097006 | regulation of plasma lipoprotein particle levels(GO:0097006) |
0.1 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.1 | 0.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 5.3 | GO:0036503 | ERAD pathway(GO:0036503) |
0.1 | 0.3 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.1 | 0.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.1 | 0.7 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.2 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.1 | 0.2 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.1 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
0.1 | 0.2 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
0.1 | 1.7 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.1 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.7 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 0.8 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
0.1 | 0.2 | GO:0010574 | regulation of vascular endothelial growth factor production(GO:0010574) |
0.1 | 0.2 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 0.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.3 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.1 | 0.8 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.1 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.4 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.1 | GO:0090494 | regulation of neurotransmitter uptake(GO:0051580) positive regulation of neurotransmitter uptake(GO:0051582) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) neurotransmitter reuptake(GO:0098810) |
0.1 | 0.2 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.1 | 0.2 | GO:0035521 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
0.1 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 0.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.1 | 0.5 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.1 | 0.1 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.1 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.1 | 0.4 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.4 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.1 | 0.6 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.1 | 0.4 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 0.1 | GO:1990839 | response to endothelin(GO:1990839) |
0.1 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.2 | GO:0021852 | pyramidal neuron migration(GO:0021852) |
0.1 | 1.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.1 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
0.1 | 0.1 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.1 | 0.2 | GO:1901799 | negative regulation of proteasomal protein catabolic process(GO:1901799) |
0.1 | 0.1 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) |
0.1 | 0.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.1 | 0.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.6 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 1.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 4.1 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
0.1 | 0.6 | GO:0006560 | proline metabolic process(GO:0006560) |
0.1 | 0.3 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
0.1 | 0.3 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.3 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.1 | 0.4 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.1 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.1 | 2.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 0.4 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.9 | GO:0043507 | positive regulation of JUN kinase activity(GO:0043507) |
0.1 | 0.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 0.1 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 0.2 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.1 | 0.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.1 | 2.0 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 2.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.2 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.1 | GO:0014009 | glial cell proliferation(GO:0014009) |
0.1 | 0.1 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.2 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.1 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
0.1 | 0.5 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.5 | GO:0050892 | intestinal absorption(GO:0050892) |
0.1 | 0.8 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 1.1 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.1 | 0.4 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.2 | GO:0021986 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.1 | 0.3 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.1 | 0.1 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.1 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 0.6 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.1 | 0.2 | GO:0014823 | response to activity(GO:0014823) |
0.1 | 0.3 | GO:0032760 | positive regulation of tumor necrosis factor production(GO:0032760) positive regulation of tumor necrosis factor superfamily cytokine production(GO:1903557) |
0.1 | 0.2 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.2 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 0.1 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.1 | 0.2 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.1 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) regulation of osteoclast proliferation(GO:0090289) |
0.1 | 0.3 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.1 | 0.1 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.1 | 0.7 | GO:0045830 | positive regulation of isotype switching(GO:0045830) |
0.1 | 0.2 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.5 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.1 | 0.2 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.1 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.7 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
0.1 | 0.6 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 1.3 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 0.2 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.1 | 0.4 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.1 | 0.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.5 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.4 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.1 | 1.1 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.1 | 0.6 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.1 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.1 | 0.2 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 | 0.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.2 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.0 | 0.3 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.0 | 0.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 1.6 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.0 | 0.1 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 0.1 | GO:0040010 | regulation of growth rate(GO:0040009) positive regulation of growth rate(GO:0040010) |
0.0 | 0.0 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.0 | 0.5 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.0 | 0.1 | GO:0000423 | macromitophagy(GO:0000423) response to mitochondrial depolarisation(GO:0098780) |
0.0 | 0.2 | GO:0042148 | strand invasion(GO:0042148) |
0.0 | 0.1 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.0 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.0 | 0.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.0 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.0 | 0.2 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.0 | 0.1 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
0.0 | 0.5 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.5 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.1 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.1 | GO:0015822 | ornithine transport(GO:0015822) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.1 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.0 | 0.1 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.0 | 0.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.1 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.0 | 0.0 | GO:0060253 | negative regulation of glial cell proliferation(GO:0060253) |
0.0 | 0.0 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.0 | 0.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.0 | 1.0 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.0 | 0.2 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.8 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.2 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.0 | 0.4 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.1 | GO:0001756 | somitogenesis(GO:0001756) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.2 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.1 | GO:2000406 | positive regulation of T cell migration(GO:2000406) |
0.0 | 2.0 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.0 | 0.1 | GO:0015793 | glycerol transport(GO:0015793) |
0.0 | 0.2 | GO:1901620 | regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901620) |
0.0 | 0.2 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.2 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
0.0 | 0.4 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 0.4 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.0 | 0.4 | GO:0046855 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.1 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.0 | 0.5 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.0 | 0.1 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.0 | 0.2 | GO:0002339 | B cell selection(GO:0002339) |
0.0 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.1 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
0.0 | 0.4 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
0.0 | 0.1 | GO:0070192 | synapsis(GO:0007129) chromosome organization involved in meiotic cell cycle(GO:0070192) |
0.0 | 0.0 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 1.1 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 0.3 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.1 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.0 | 0.3 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.0 | 0.7 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.3 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.0 | 0.1 | GO:2000403 | positive regulation of lymphocyte migration(GO:2000403) |
0.0 | 0.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.0 | 0.5 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.9 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.0 | 0.1 | GO:2001169 | regulation of ATP biosynthetic process(GO:2001169) |
0.0 | 0.0 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.0 | 0.4 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.4 | GO:0042098 | T cell proliferation(GO:0042098) |
0.0 | 0.2 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
0.0 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.0 | 0.2 | GO:0051930 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.0 | 0.6 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.0 | 0.2 | GO:0046060 | dATP metabolic process(GO:0046060) |
0.0 | 1.6 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.0 | 0.2 | GO:0032715 | negative regulation of interleukin-6 production(GO:0032715) |
0.0 | 0.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.1 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.3 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.1 | GO:0009650 | UV protection(GO:0009650) |
0.0 | 0.0 | GO:1990523 | bone regeneration(GO:1990523) |
0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.9 | GO:0030279 | negative regulation of ossification(GO:0030279) |
0.0 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.0 | 0.3 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.0 | 0.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.2 | GO:0051882 | mitochondrial depolarization(GO:0051882) regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.0 | 0.1 | GO:0001821 | histamine secretion(GO:0001821) |
0.0 | 0.2 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.0 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.1 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.2 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.1 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.0 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.0 | 0.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.0 | 0.0 | GO:0014841 | skeletal muscle satellite cell proliferation(GO:0014841) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
0.0 | 0.6 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.0 | 0.7 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.2 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.2 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.0 | 0.0 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
0.0 | 0.0 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.0 | 0.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
0.0 | 0.1 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.0 | 0.1 | GO:1902035 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:0071480 | cellular response to gamma radiation(GO:0071480) |
0.0 | 0.0 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.0 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.2 | GO:1990748 | cellular detoxification(GO:1990748) |
0.0 | 0.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.0 | 0.1 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.0 | 0.5 | GO:1902652 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.0 | 0.2 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.0 | 0.0 | GO:0044154 | histone H3-K14 acetylation(GO:0044154) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.3 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.1 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.9 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.2 | GO:0030033 | microvillus assembly(GO:0030033) |
0.0 | 0.8 | GO:0006417 | regulation of translation(GO:0006417) |
0.0 | 0.3 | GO:0009411 | response to UV(GO:0009411) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.2 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
0.0 | 0.1 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
0.0 | 0.5 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.1 | GO:0001889 | liver development(GO:0001889) |
0.0 | 0.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 0.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.0 | 0.3 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.0 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.0 | 0.1 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.0 | 0.0 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.0 | 0.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.0 | 0.1 | GO:0070265 | necrotic cell death(GO:0070265) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.0 | 0.0 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.0 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.0 | 0.6 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.0 | 0.0 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0048678 | response to axon injury(GO:0048678) |
0.0 | 0.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.0 | 0.0 | GO:0006071 | glycerol metabolic process(GO:0006071) |
0.0 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.0 | GO:1901355 | response to rapamycin(GO:1901355) |
0.0 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 0.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.0 | 0.2 | GO:0030850 | prostate gland development(GO:0030850) |
0.0 | 0.0 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
0.0 | 0.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.1 | GO:0046415 | urate metabolic process(GO:0046415) |
0.0 | 0.1 | GO:0061647 | histone H3-K9 modification(GO:0061647) |
0.0 | 0.1 | GO:0003085 | negative regulation of systemic arterial blood pressure(GO:0003085) |
0.0 | 0.3 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.1 | GO:0050912 | detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
0.0 | 0.1 | GO:0036233 | glycine import(GO:0036233) |
0.0 | 0.4 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
0.0 | 0.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.0 | 0.0 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
0.0 | 0.1 | GO:0016233 | telomere capping(GO:0016233) regulation of telomere capping(GO:1904353) |
0.0 | 0.1 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.3 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.1 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.0 | 0.1 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.0 | 0.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.5 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.0 | GO:0042748 | circadian sleep/wake cycle, non-REM sleep(GO:0042748) |
0.0 | 1.3 | GO:0008033 | tRNA processing(GO:0008033) |
0.0 | 0.0 | GO:0032847 | regulation of cellular pH reduction(GO:0032847) |
0.0 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
0.0 | 0.1 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
0.0 | 0.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.1 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
0.0 | 0.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.3 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.0 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.0 | 0.2 | GO:0060538 | skeletal muscle organ development(GO:0060538) |
0.0 | 0.9 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.0 | GO:0008354 | germ cell migration(GO:0008354) |
0.0 | 0.0 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.0 | 0.7 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 0.2 | GO:0050871 | positive regulation of B cell activation(GO:0050871) |
0.0 | 0.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.0 | 0.3 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.1 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.3 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.0 | 1.6 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 0.1 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.0 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.0 | 0.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.0 | 0.1 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
0.0 | 0.1 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.0 | 0.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.1 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.0 | 0.0 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.3 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
0.0 | 0.1 | GO:1990173 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.2 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.5 | GO:0007019 | microtubule depolymerization(GO:0007019) |
0.0 | 0.0 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.0 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 0.0 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.0 | 0.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.0 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.0 | 0.0 | GO:0071476 | hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.0 | 0.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 6.8 | GO:0043259 | laminin-10 complex(GO:0043259) |
1.2 | 3.5 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.1 | 5.5 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.0 | 3.9 | GO:0060187 | cell pole(GO:0060187) |
0.9 | 2.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.8 | 4.1 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.7 | 6.1 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.7 | 5.4 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 7.0 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 3.2 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.6 | 1.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.6 | 1.8 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.6 | 3.6 | GO:0097513 | myosin II filament(GO:0097513) |
0.6 | 2.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.6 | 2.2 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.5 | 2.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.5 | 1.0 | GO:0030008 | TRAPP complex(GO:0030008) |
0.5 | 1.5 | GO:0071953 | elastic fiber(GO:0071953) |
0.5 | 0.5 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 1.5 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
0.5 | 2.0 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
0.5 | 2.9 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
0.5 | 1.9 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.5 | 1.9 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 6.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.5 | 1.4 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.5 | 2.9 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.5 | 2.3 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.5 | 4.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.4 | 1.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.4 | 1.3 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.4 | 3.5 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.4 | 1.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.4 | 2.0 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.4 | 2.7 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 1.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.4 | 0.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.4 | 0.7 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 2.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.3 | 1.0 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) |
0.3 | 1.0 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.3 | 3.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.3 | GO:0090537 | CERF complex(GO:0090537) |
0.3 | 1.0 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 2.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.3 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
0.3 | 2.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.3 | 2.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.3 | 0.9 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.3 | 0.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 0.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.8 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.3 | 0.5 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 2.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.3 | 3.2 | GO:0016342 | catenin complex(GO:0016342) |
0.3 | 0.8 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 3.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 0.3 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 2.1 | GO:0097342 | ripoptosome(GO:0097342) |
0.3 | 3.1 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.3 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.3 | 1.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.3 | 5.4 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 7.3 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.3 | 2.0 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.7 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.2 | 1.5 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 3.5 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.2 | 0.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 1.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 6.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.2 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.1 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 0.9 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.9 | GO:0035339 | SPOTS complex(GO:0035339) |
0.2 | 3.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.7 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.2 | 0.7 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.2 | 2.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 1.7 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.2 | 0.9 | GO:0032280 | symmetric synapse(GO:0032280) |
0.2 | 4.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.2 | 1.1 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.2 | 1.5 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 3.5 | GO:0005605 | basal lamina(GO:0005605) |
0.2 | 1.9 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 1.4 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.2 | 2.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 1.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.2 | 0.8 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.2 | 0.4 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.2 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 0.8 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.2 | 3.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 0.6 | GO:1990047 | spindle matrix(GO:1990047) |
0.2 | 0.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.2 | 2.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.2 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.2 | 1.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 6.7 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 2.5 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.2 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 4.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.2 | 0.2 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.2 | 0.5 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
0.2 | 0.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 1.3 | GO:0097422 | tubular endosome(GO:0097422) |
0.2 | 26.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.4 | GO:0070187 | telosome(GO:0070187) |
0.2 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.7 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.2 | 2.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 1.6 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 1.0 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 1.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 2.7 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.2 | 0.7 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.2 | 0.5 | GO:0042585 | germinal vesicle(GO:0042585) |
0.2 | 0.3 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 0.5 | GO:0018444 | translation release factor complex(GO:0018444) |
0.2 | 0.7 | GO:0016528 | sarcoplasm(GO:0016528) |
0.2 | 0.7 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.2 | 0.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.2 | 0.6 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.2 | 2.5 | GO:0036038 | MKS complex(GO:0036038) |
0.2 | 10.4 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 0.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 1.3 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 1.3 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 3.8 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 0.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 0.3 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 13.5 | GO:0005901 | caveola(GO:0005901) |
0.1 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.1 | 0.4 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
0.1 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.1 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 5.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.6 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
0.1 | 1.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.1 | 1.4 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 3.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 1.5 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.1 | 2.0 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.1 | 2.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.7 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 6.3 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 1.0 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 0.5 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.1 | 0.9 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) TAP complex(GO:0042825) |
0.1 | 0.5 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.6 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.9 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.1 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 1.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 1.9 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 2.2 | GO:0071564 | npBAF complex(GO:0071564) |
0.1 | 0.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.9 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 4.4 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 8.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.1 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.1 | GO:0001740 | Barr body(GO:0001740) |
0.1 | 0.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.1 | 0.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 9.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 6.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.3 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.4 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 0.6 | GO:0001940 | male pronucleus(GO:0001940) |
0.1 | 0.6 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.6 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
0.1 | 3.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 2.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.1 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.1 | 1.2 | GO:0045095 | keratin filament(GO:0045095) |
0.1 | 0.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.5 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.1 | 0.4 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 2.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.5 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 0.3 | GO:0031983 | vesicle lumen(GO:0031983) |
0.1 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.3 | GO:0031251 | PAN complex(GO:0031251) |
0.1 | 0.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.1 | 1.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.1 | 0.3 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 2.0 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 0.9 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.1 | GO:0098830 | presynaptic endosome(GO:0098830) |
0.1 | 0.1 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0097447 | dendritic tree(GO:0097447) |
0.1 | 0.2 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 1.0 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 1.0 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 6.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.4 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 2.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.8 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.2 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.5 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.1 | 0.8 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.5 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 1.9 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 6.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.1 | 0.4 | GO:0070826 | paraferritin complex(GO:0070826) |
0.1 | 4.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.1 | 0.2 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.1 | 0.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 2.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.6 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 1.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.6 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.3 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.1 | 1.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.3 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 3.0 | GO:0005925 | focal adhesion(GO:0005925) |
0.1 | 1.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.0 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 2.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 2.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 3.9 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 1.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.1 | 0.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.1 | 0.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 0.5 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.2 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.2 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.1 | 1.9 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.1 | 2.0 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 1.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.1 | 3.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.2 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
0.1 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.1 | 0.4 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.5 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 6.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.1 | 4.6 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 4.5 | GO:0042641 | actomyosin(GO:0042641) |
0.0 | 1.3 | GO:0035861 | site of double-strand break(GO:0035861) |
0.0 | 0.5 | GO:0042571 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 2.5 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 10.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.5 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 1.1 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 1.4 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.2 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.4 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.0 | 0.9 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.0 | 0.2 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.0 | 0.4 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.0 | 1.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.2 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.0 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.3 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.5 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.2 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 0.6 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.2 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 0.1 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
0.0 | 1.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 0.3 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.5 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.6 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.1 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.0 | 0.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.5 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 54.1 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.2 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.2 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.0 | 0.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0000776 | kinetochore(GO:0000776) |
0.0 | 1.0 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.1 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 1.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.1 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 1.7 | GO:0019867 | outer membrane(GO:0019867) |
0.0 | 0.3 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.9 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 3.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.1 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.0 | GO:0005814 | centriole(GO:0005814) |
0.0 | 1.0 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 13.5 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.0 | 0.1 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 0.2 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.0 | 0.0 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.0 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 3.6 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
1.2 | 8.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
1.1 | 3.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 5.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.1 | 8.4 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 2.9 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.9 | 2.6 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.8 | 2.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.8 | 2.3 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.7 | 3.0 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.7 | 2.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.7 | 2.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.7 | 2.0 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.7 | 6.0 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 2.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.6 | 2.5 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.6 | 1.8 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.6 | 1.8 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.6 | 1.8 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.6 | 1.8 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.6 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.6 | 0.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.6 | 3.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.6 | 1.7 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.6 | 2.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.5 | 2.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.5 | 2.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.5 | 1.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.5 | 2.1 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.5 | 2.1 | GO:0005113 | patched binding(GO:0005113) |
0.5 | 2.5 | GO:0004342 | glucosamine-6-phosphate deaminase activity(GO:0004342) |
0.5 | 9.6 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.5 | 2.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.5 | 11.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 1.5 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.5 | 2.9 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
0.5 | 2.4 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.5 | 1.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.5 | 1.4 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.5 | 3.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.5 | 1.4 | GO:0004637 | phosphoribosylamine-glycine ligase activity(GO:0004637) |
0.5 | 1.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.5 | 2.3 | GO:1990188 | euchromatin binding(GO:1990188) |
0.5 | 2.3 | GO:0038132 | neuregulin binding(GO:0038132) |
0.4 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 1.3 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.4 | 0.4 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.4 | 3.8 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.4 | 0.9 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.4 | 7.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 1.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 0.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 0.8 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.4 | 8.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.4 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
0.4 | 1.2 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.4 | 2.7 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 1.6 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.4 | 7.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.4 | 2.3 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.4 | 1.9 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.4 | 1.5 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.4 | 2.3 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.4 | 1.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.4 | 1.5 | GO:0050436 | microfibril binding(GO:0050436) |
0.4 | 0.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 1.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.4 | 1.5 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.4 | 0.7 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.4 | 2.2 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.4 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 1.8 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.4 | 0.4 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.4 | 1.1 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.4 | 1.1 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.4 | 1.4 | GO:1990254 | keratin filament binding(GO:1990254) |
0.3 | 3.1 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 2.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.3 | 3.4 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.3 | 1.0 | GO:0051425 | PTB domain binding(GO:0051425) |
0.3 | 2.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 1.0 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.3 | 1.0 | GO:0005118 | sevenless binding(GO:0005118) |
0.3 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.3 | 2.9 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 1.3 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.3 | 0.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 5.5 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.3 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.3 | 1.0 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 1.6 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.3 | 1.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 3.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.3 | 3.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 0.6 | GO:0001729 | ceramide kinase activity(GO:0001729) |
0.3 | 3.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 3.1 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.3 | 2.1 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.3 | 1.8 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.3 | 1.2 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.3 | 3.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.3 | 3.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.3 | 11.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.3 | 1.8 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 3.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 2.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.3 | 2.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 1.1 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.3 | 1.4 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 1.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 1.4 | GO:0070728 | leucine binding(GO:0070728) |
0.3 | 0.3 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.3 | 2.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.3 | 0.8 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 5.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 1.4 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.3 | 4.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.3 | 2.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.3 | 1.4 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.3 | 8.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.3 | 0.8 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.8 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.3 | 0.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.3 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.3 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 0.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.3 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 1.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 1.3 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 1.0 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 0.8 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.3 | 2.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.2 | 0.7 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 1.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.2 | 0.7 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.2 | 1.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.2 | 0.7 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
0.2 | 11.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.2 | 2.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 5.8 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 2.6 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.2 | 0.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
0.2 | 0.5 | GO:0001156 | TFIIIC-class transcription factor binding(GO:0001156) |
0.2 | 0.7 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.2 | 1.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.2 | 0.9 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.8 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.2 | 1.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.2 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.2 | 1.6 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.2 | 0.9 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
0.2 | 0.7 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.2 | 1.5 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.2 | 2.4 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 1.1 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.2 | 1.3 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.2 | 0.4 | GO:0086075 | gap junction channel activity involved in cardiac conduction electrical coupling(GO:0086075) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.2 | 0.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.2 | 0.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 6.5 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.8 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.8 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.2 | 0.2 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.2 | 0.6 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.2 | 1.0 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.2 | 1.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.2 | 6.9 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 2.4 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 1.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.2 | 1.6 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.2 | 0.6 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.2 | 0.6 | GO:0030371 | translation repressor activity(GO:0030371) |
0.2 | 0.4 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.2 | 1.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 1.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.2 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.2 | 0.6 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.2 | 1.7 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 1.3 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.2 | 1.5 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.2 | 0.6 | GO:0001565 | phorbol ester receptor activity(GO:0001565) non-kinase phorbol ester receptor activity(GO:0001566) |
0.2 | 3.8 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 0.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 1.7 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.2 | 3.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 2.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.2 | 2.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.7 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 1.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.2 | 0.7 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.2 | 0.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 1.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 0.5 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 0.5 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.2 | 3.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.2 | 2.1 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.4 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.9 | GO:0043532 | angiostatin binding(GO:0043532) |
0.2 | 0.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.2 | 1.0 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.2 | 0.2 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.2 | 0.2 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 3.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 7.8 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.2 | 0.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.5 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.2 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 3.0 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 4.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 0.5 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 0.2 | GO:0000992 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.2 | 7.1 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.2 | 0.5 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 0.6 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.2 | 1.8 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 1.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 2.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.2 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.8 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 2.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 0.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 2.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.2 | 0.9 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.2 | 1.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.2 | 4.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 1.1 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.2 | 1.1 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.2 | 1.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.2 | 0.9 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 2.8 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 11.5 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 0.4 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.1 | 3.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 1.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 1.5 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.4 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.1 | 1.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.1 | 0.9 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.4 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.1 | 1.0 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.4 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 1.8 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 1.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.5 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 0.4 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.1 | 0.8 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 2.3 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.5 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.1 | 0.1 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 2.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 0.7 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 0.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) TFIIB-class transcription factor binding(GO:0001093) |
0.1 | 0.7 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 1.7 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 2.5 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.1 | 3.5 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 1.0 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.1 | 2.2 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.5 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 1.8 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.1 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.1 | 0.5 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 1.1 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.9 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.7 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 1.2 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.1 | 0.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.1 | 0.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 1.3 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 5.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.9 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 2.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.4 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.1 | 1.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.6 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.1 | 0.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 0.2 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.5 | GO:0000700 | mismatch base pair DNA N-glycosylase activity(GO:0000700) |
0.1 | 4.8 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.7 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.6 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
0.1 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 2.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 1.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 4.1 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.3 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
0.1 | 1.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 2.1 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 2.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.1 | 0.2 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.1 | 0.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 1.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 0.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 11.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 0.5 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.1 | 3.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 0.6 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.5 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
0.1 | 0.2 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
0.1 | 0.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.9 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.1 | 0.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.1 | 0.8 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 1.1 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.3 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.7 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.2 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.1 | 0.5 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.1 | 0.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 1.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 2.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.2 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
0.1 | 0.5 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.4 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 1.6 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 1.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.4 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 21.7 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.4 | GO:0003680 | AT DNA binding(GO:0003680) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 4.2 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.1 | 0.2 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.3 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.3 | GO:0004454 | ketohexokinase activity(GO:0004454) |
0.1 | 0.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.1 | 0.7 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.3 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 0.4 | GO:0015093 | iron ion transmembrane transporter activity(GO:0005381) ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 5.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.1 | 1.6 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 2.9 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.1 | 0.3 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
0.1 | 1.8 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.1 | 1.1 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:2001070 | starch binding(GO:2001070) |
0.1 | 0.3 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.1 | 0.2 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 1.0 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 0.4 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 1.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 1.9 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 1.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.5 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
0.1 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 6.1 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 1.0 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.8 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.7 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.1 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.1 | 0.2 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
0.1 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.9 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.7 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 9.2 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 0.2 | GO:0051870 | methotrexate binding(GO:0051870) |
0.1 | 0.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.2 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.1 | 0.1 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 1.0 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 0.2 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.1 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.3 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 2.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 0.5 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.1 | 0.9 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.2 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 5.4 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.1 | 6.4 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.1 | GO:1990269 | RNA polymerase II C-terminal domain phosphoserine binding(GO:1990269) |
0.1 | 0.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.4 | GO:0043176 | amine binding(GO:0043176) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.1 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.1 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 1.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.2 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.1 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.1 | 0.2 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.1 | 0.2 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.1 | 0.2 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 0.2 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 0.7 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.1 | 0.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.1 | GO:0005402 | cation:sugar symporter activity(GO:0005402) |
0.1 | 2.4 | GO:0032934 | sterol binding(GO:0032934) |
0.1 | 0.2 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 0.1 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.1 | 0.2 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
0.1 | 3.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.1 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.1 | 0.4 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.1 | 0.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.1 | 0.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.2 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 1.7 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.2 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.0 | 0.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.8 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 0.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 1.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.1 | GO:0008311 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) double-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008311) |
0.0 | 0.0 | GO:0031208 | POZ domain binding(GO:0031208) |
0.0 | 0.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 6.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.2 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.0 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.0 | 1.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.2 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.0 | 1.3 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.3 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
0.0 | 0.2 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.0 | 0.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.0 | 0.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.9 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.0 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.1 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.0 | 0.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.0 | 5.7 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 0.6 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 0.1 | GO:0019841 | retinal binding(GO:0016918) retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.0 | 0.3 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.0 | 0.1 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.0 | 0.1 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
0.0 | 0.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.0 | 0.3 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 0.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.0 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.4 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.4 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.2 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.0 | 1.0 | GO:0050660 | flavin adenine dinucleotide binding(GO:0050660) |
0.0 | 0.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.0 | 0.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 1.0 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.1 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 0.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 4.0 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.0 | 0.1 | GO:0042834 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.1 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.0 | 0.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.0 | 0.3 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.0 | 0.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.0 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.0 | 0.1 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.0 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.0 | 0.1 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
0.0 | 0.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 1.8 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.3 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 0.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.5 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.2 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 1.8 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.0 | 0.1 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 0.2 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.0 | 0.1 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.0 | 0.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.0 | 0.7 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.0 | 0.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.0 | 0.1 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.0 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.0 | 0.4 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.0 | 2.0 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 5.4 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 4.4 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.1 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.0 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.1 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.5 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.0 | 5.3 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.0 | 0.5 | GO:0008528 | G-protein coupled peptide receptor activity(GO:0008528) |
0.0 | 0.0 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.7 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.4 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.1 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
0.0 | 0.1 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
0.0 | 0.1 | GO:0045118 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.0 | 0.5 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.0 | 0.2 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.3 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.0 | 0.2 | GO:0004702 | receptor signaling protein serine/threonine kinase activity(GO:0004702) |
0.0 | 0.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.0 | 1.5 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.0 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.3 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 1.2 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 0.1 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
Gene overrepresentation in C2:CP category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 9.9 | PID_INTEGRIN4_PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.5 | 14.5 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
0.4 | 2.9 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
0.4 | 24.5 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
0.4 | 18.8 | PID_BMP_PATHWAY | BMP receptor signaling |
0.3 | 7.5 | PID_BETA_CATENIN_DEG_PATHWAY | Degradation of beta catenin |
0.3 | 9.6 | PID_PS1_PATHWAY | Presenilin action in Notch and Wnt signaling |
0.3 | 1.1 | ST_GRANULE_CELL_SURVIVAL_PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 1.4 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
0.2 | 6.3 | PID_MYC_PATHWAY | C-MYC pathway |
0.2 | 2.6 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 6.5 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 1.5 | SIG_CHEMOTAXIS | Genes related to chemotaxis |
0.2 | 6.7 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
0.2 | 12.6 | PID_P53_REGULATION_PATHWAY | p53 pathway |
0.2 | 4.6 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.0 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 11.4 | PID_HEDGEHOG_GLI_PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 6.2 | PID_ECADHERIN_KERATINOCYTE_PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 3.9 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
0.2 | 5.5 | PID_IL1_PATHWAY | IL1-mediated signaling events |
0.2 | 1.4 | SA_G2_AND_M_PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 2.9 | ST_WNT_BETA_CATENIN_PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 1.9 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
0.2 | 10.2 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.3 | ST_INTERFERON_GAMMA_PATHWAY | Interferon gamma pathway. |
0.1 | 1.3 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.1 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.3 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.4 | PID_S1P_S1P2_PATHWAY | S1P2 pathway |
0.1 | 7.8 | PID_E2F_PATHWAY | E2F transcription factor network |
0.1 | 5.4 | PID_ECADHERIN_NASCENT_AJ_PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 4.2 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
0.1 | 0.4 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
0.1 | 0.5 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 2.1 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 0.4 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
0.1 | 0.6 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 1.6 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
0.1 | 0.2 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 3.6 | PID_BARD1_PATHWAY | BARD1 signaling events |
0.1 | 1.4 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
0.1 | 1.5 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 3.9 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.2 | ST_ADRENERGIC | Adrenergic Pathway |
0.1 | 0.2 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
0.1 | 4.4 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.5 | PID_WNT_NONCANONICAL_PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 1.8 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
0.1 | 0.4 | PID_TCR_RAS_PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.3 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.3 | PID_IGF1_PATHWAY | IGF1 pathway |
0.1 | 3.0 | PID_ATR_PATHWAY | ATR signaling pathway |
0.1 | 3.5 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.6 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
0.1 | 3.1 | PID_REELIN_PATHWAY | Reelin signaling pathway |
0.1 | 0.2 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 0.5 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.9 | PID_NETRIN_PATHWAY | Netrin-mediated signaling events |
0.1 | 0.1 | PID_ALK2_PATHWAY | ALK2 signaling events |
0.1 | 1.2 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
0.1 | 0.3 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 3.3 | PID_TELOMERASE_PATHWAY | Regulation of Telomerase |
0.1 | 0.2 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 2.4 | PID_AJDISS_2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 1.0 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 1.0 | PID_PI3KCI_AKT_PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 1.1 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 4.3 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
0.1 | 0.6 | PID_IL23_PATHWAY | IL23-mediated signaling events |
0.1 | 1.0 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.5 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.7 | PID_AMB2_NEUTROPHILS_PATHWAY | amb2 Integrin signaling |
0.1 | 2.8 | PID_LKB1_PATHWAY | LKB1 signaling events |
0.1 | 2.5 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 0.5 | PID_CD40_PATHWAY | CD40/CD40L signaling |
0.1 | 1.7 | PID_TAP63_PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.2 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
0.1 | 0.4 | PID_EPO_PATHWAY | EPO signaling pathway |
0.0 | 2.6 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.4 | PID_ALK1_PATHWAY | ALK1 signaling events |
0.0 | 0.1 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.8 | PID_VEGFR1_2_PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.0 | 0.9 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
0.0 | 0.6 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
0.0 | 4.9 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.4 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | SA_PROGRAMMED_CELL_DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | PID_AP1_PATHWAY | AP-1 transcription factor network |
0.0 | 1.2 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
0.0 | 1.3 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.6 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
0.0 | 0.6 | PID_ECADHERIN_STABILIZATION_PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | ST_P38_MAPK_PATHWAY | p38 MAPK Pathway |
0.0 | 0.5 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
0.0 | 0.7 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | PID_TOLL_ENDOGENOUS_PATHWAY | Endogenous TLR signaling |
0.0 | 0.1 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
0.0 | 0.2 | PID_IL3_PATHWAY | IL3-mediated signaling events |
0.0 | 0.2 | PID_P38_ALPHA_BETA_PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID_SHP2_PATHWAY | SHP2 signaling |
0.0 | 1.8 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.0 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
Gene overrepresentation in C2:CP:REACTOME category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.2 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.7 | 4.7 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.6 | 1.7 | REACTOME_RECYCLING_PATHWAY_OF_L1 | Genes involved in Recycling pathway of L1 |
0.5 | 14.7 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
0.5 | 8.2 | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.4 | 14.7 | REACTOME_MYOGENESIS | Genes involved in Myogenesis |
0.4 | 3.5 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.4 | 10.7 | REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.3 | 4.1 | REACTOME_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 3.7 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 6.8 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 8.4 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 8.9 | REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.3 | 10.8 | REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.3 | 7.3 | REACTOME_SIGNALING_BY_HIPPO | Genes involved in Signaling by Hippo |
0.3 | 4.6 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 3.9 | REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.3 | 4.1 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 4.0 | REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 4.3 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 0.5 | REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.3 | 3.1 | REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.3 | 0.8 | REACTOME_PLATELET_CALCIUM_HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 8.8 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.3 | 2.0 | REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 0.9 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
0.2 | 0.9 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.2 | 1.1 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 3.0 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
0.2 | 4.5 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
0.2 | 4.2 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 8.1 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.2 | 6.6 | REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
0.2 | 1.8 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 1.2 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 0.6 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.6 | REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 3.1 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.2 | 4.7 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 1.2 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 1.7 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.4 | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.2 | 1.2 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 2.1 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
0.2 | 4.8 | REACTOME_TRIGLYCERIDE_BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 2.2 | REACTOME_STEROID_HORMONES | Genes involved in Steroid hormones |
0.2 | 1.7 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
0.2 | 4.2 | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 2.0 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
0.2 | 6.2 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 1.8 | REACTOME_COPI_MEDIATED_TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 1.2 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.0 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 1.6 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 2.9 | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.3 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.1 | 4.6 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
0.1 | 2.1 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.0 | REACTOME_FGFR4_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.1 | 2.2 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 5.1 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 0.3 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 2.8 | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.1 | 2.1 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.6 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
0.1 | 2.5 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.8 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.1 | 0.2 | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.1 | REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 0.3 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 1.0 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.4 | REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.8 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.7 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.4 | REACTOME_ETHANOL_OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.6 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.1 | 0.2 | REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.1 | 8.1 | REACTOME_UNFOLDED_PROTEIN_RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.8 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.9 | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.6 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.1 | 1.1 | REACTOME_MUSCLE_CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.3 | REACTOME_PIP3_ACTIVATES_AKT_SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.1 | 1.3 | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.9 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.1 | 0.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.2 | REACTOME_ENOS_ACTIVATION_AND_REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 1.1 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.1 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 1.6 | REACTOME_HS_GAG_DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.4 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 0.7 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 0.4 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 1.6 | REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.9 | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | Genes involved in Prolonged ERK activation events |
0.1 | 1.3 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.1 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 0.5 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 0.8 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.2 | REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.3 | REACTOME_CTLA4_INHIBITORY_SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.1 | 1.0 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 1.2 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 1.0 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.8 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.6 | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 3.3 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 1.5 | REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 0.9 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.0 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
0.1 | 0.3 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.3 | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.1 | 0.3 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.4 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
0.1 | 0.6 | REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 1.2 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 0.4 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 0.4 | REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 0.5 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 0.1 | REACTOME_MRNA_CAPPING | Genes involved in mRNA Capping |
0.1 | 2.0 | REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 1.2 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.5 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 0.4 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 5.2 | REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 0.5 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
0.0 | 0.5 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 1.6 | REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.4 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.6 | REACTOME_REGULATION_OF_KIT_SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 1.1 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 0.0 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 0.7 | REACTOME_PHASE_II_CONJUGATION | Genes involved in Phase II conjugation |
0.0 | 0.8 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.6 | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
0.0 | 0.9 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.6 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
0.0 | 0.2 | REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.0 | 0.4 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.0 | 0.1 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.0 | 0.5 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.2 | REACTOME_MEIOSIS | Genes involved in Meiosis |
0.0 | 0.6 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
0.0 | 0.7 | REACTOME_FANCONI_ANEMIA_PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.9 | REACTOME_SIGNALING_BY_FGFR1_MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.0 | 0.6 | REACTOME_DEADENYLATION_OF_MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.1 | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 1.9 | REACTOME_GLUCOSE_METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.7 | REACTOME_SIGNALING_BY_ROBO_RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 0.3 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
0.0 | 1.3 | REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.8 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.1 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
0.0 | 1.9 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.3 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.4 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.0 | REACTOME_ORC1_REMOVAL_FROM_CHROMATIN | Genes involved in Orc1 removal from chromatin |
0.0 | 0.7 | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.1 | REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_ | Genes involved in Formation of RNA Pol II elongation complex |
0.0 | 1.6 | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME_PKB_MEDIATED_EVENTS | Genes involved in PKB-mediated events |
0.0 | 0.2 | REACTOME_PURINE_CATABOLISM | Genes involved in Purine catabolism |
0.0 | 0.3 | REACTOME_GLOBAL_GENOMIC_NER_GG_NER | Genes involved in Global Genomic NER (GG-NER) |
0.0 | 0.1 | REACTOME_PECAM1_INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.1 | REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.2 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 0.3 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.0 | 0.4 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.6 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.1 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.0 | 0.3 | REACTOME_IL_3_5_AND_GM_CSF_SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.9 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
0.0 | 0.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.2 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.2 | REACTOME_SIGNALING_BY_ILS | Genes involved in Signaling by Interleukins |
0.0 | 1.0 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |